These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9847631)

  • 1. [Almitrin and patients with COPD--a dangerous combination?].
    Köhler D; Criée C; Raschke F
    Pneumologie; 1998 Oct; 52(10):541-2. PubMed ID: 9847631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Almitrine in therapy of chronic obstructive respiratory tract diseases with hypoxemia--a clinical multicenter study comparing 2 dosages].
    Nowak D; Wywiol A; Magnussen H
    Pneumologie; 1998 Mar; 52(3):121-7. PubMed ID: 9564184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Almitrine bismesylate in chronic obstructive pulmonary disease].
    González-Ruiz JM
    Med Clin (Barc); 1993 Mar; 100(9):356-7. PubMed ID: 8455416
    [No Abstract]   [Full Text] [Related]  

  • 4. [Almitrine: a peripheral respiratory stimulant in chronic obstructive pulmonary disease].
    Rubio Terrés C; López Alvarez M; Vargas Castrillón E
    Rev Clin Esp; 1990 Feb; 186(2):84-7. PubMed ID: 2158666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Almitrine Infusion During Veno-Venous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome in Adults.
    Esnault P; Hraiech S; Bordes J; Forel JM; Adda M; Rambaud R; Lehingue S; Roch A; Papazian L; Guervilly C
    Anesth Analg; 2019 Aug; 129(2):e48-e51. PubMed ID: 29337729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypoxaemia in chronic obstructive pulmonary disease (COPD) and its management.
    Voisin C
    Wiad Lek; 1998; 51(1-2):11-4. PubMed ID: 9608825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of oral almitrine and medroxyprogesterone acetate: effect on arterial blood gases in chronic obstructive pulmonary disease.
    Pinet C; Tessonnier F; Ravel T; Orehek J
    Respir Med; 2001 Jul; 95(7):602-5. PubMed ID: 11453318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible hepatic cytolysis during almitrine bismesylate treatment for posttraumatic ARDS.
    Sicsic JC; Jugan E; Moine P; Edouard A; Samii K
    Intensive Care Med; 1996 Feb; 22(2):173-4. PubMed ID: 8857125
    [No Abstract]   [Full Text] [Related]  

  • 9. The best approach to ARDS?
    Blaise G; Troncy E
    Can J Anaesth; 1998 May; 45(5 Pt 1):393-6. PubMed ID: 9598251
    [No Abstract]   [Full Text] [Related]  

  • 10. Ten cases of peripheral neuropathy during treatment with almitrine in COPD patients.
    Gerard M; Leger P; Couturier JC; Robert D
    Eur J Respir Dis Suppl; 1986; 146():591-6. PubMed ID: 3023128
    [No Abstract]   [Full Text] [Related]  

  • 11. VA/Q ratios distribution and oral almitrine bismesylate in COPD patients under mechanical ventilation: preliminary results.
    Castaing Y; Manier G; Guenard H
    Eur J Respir Dis Suppl; 1983; 126():243-7. PubMed ID: 6586438
    [No Abstract]   [Full Text] [Related]  

  • 12. Almitrine and NO in acute respiratory distress syndrome: two pieces of the same puzzle?
    Puybasset L; Rouby JJ
    Eur Respir J; 1999 Dec; 14(6):1244-5. PubMed ID: 10624749
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary alveolar hypoventilation and response to the respiratory stimulant almitrine.
    Antic N; McEvoy RD
    Intern Med J; 2002 Dec; 32(12):622-4. PubMed ID: 12512759
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combination of thiotropium bromide with almitrine and pulmonary rehabilitation in the treatment of patients with chronic obstructive pulmonary disease].
    Titova ON; Ignat'ev VA; Didur MD; Kameneva MIu; Sukhovskaia OA
    Ter Arkh; 2008; 80(3):28-33. PubMed ID: 18441680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Respiratory stimulants and COPD].
    Izquierdo J; Morera J
    Rev Clin Esp; 1994 Dec; 194(12):1003-5. PubMed ID: 7863044
    [No Abstract]   [Full Text] [Related]  

  • 16. High or low doses of almitrine bismesylate in ARDS patients responding to inhaled NO and receiving norepinephrine?
    Roch A; Papazian L; Bregeon F; Gainnier M; Michelet P; Thirion X; Saux P; Thomas P; Jammes Y; Auffray JP
    Intensive Care Med; 2001 Nov; 27(11):1737-43. PubMed ID: 11810116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in treatment of chronic obstructive lung disease with almitrine bis-mesylate.
    Huchon G
    Postgrad Med J; 1983; 59 Suppl 3():66-7. PubMed ID: 6615607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Doxapram treatment in acute deterioration of chronic obstructive pulmonary disease].
    Kiszka-Kanowitz M; Matzen P
    Ugeskr Laeger; 1997 Oct; 159(41):6055-6. PubMed ID: 9381576
    [No Abstract]   [Full Text] [Related]  

  • 19. Almitrine bismesylate: current status.
    Tweney J
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():153s-163s. PubMed ID: 3318970
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacology of almitrine bismesylate.
    Pariente R
    Eur J Respir Dis Suppl; 1983; 126():271-4. PubMed ID: 6586441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.